Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2017
Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma
Martin Dreyling, Armando Santoro, Luigina Mollica, et al.
Blood Advances
|
June 5, 2023
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study
Pierre Fenaux, Marco Gobbi, Patricia L Kropf, et al.
Hemasphere
|
August 5, 2021
Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial
Hartmut Döhner, Argiris Symeonidis, Dries Deeren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2019
Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma
Owen A O'Connor, Muhit Özcan, Eric D Jacobsen, et al.
British Journal of Haematology
|
May 21, 2021
Screening and monitoring of the BTK<sup>C481S</sup> mutation in a real-world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy
Csaba Bödör, Lili Kotmayer, Tamás László, et al.
Mycoses
|
September 5, 2022
Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope
Maria Ilaria Del Principe, Danila Seidel, Marianna Criscuolo, et al.
Leukemia
|
May 5, 2021
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
Michael Grever, Leslie Andritsos, Versha Banerji, et al.
Leukemia & Lymphoma
|
September 7, 2022
Development of a distributed international patient data registry for hairy cell leukemia
Leslie A Andritsos, Mirela Anghelina, Jasmine Neal, et al.
Blood
|
December 2, 2016
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
Michael R Grever, Omar Abdel-Wahab, Leslie A Andritsos, et al.
The Journal of Pathology. Clinical Research
|
November 21, 2023
Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation
Tamás László, Lili Kotmayer, Viktória Fésüs, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2017
Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma
Martin Dreyling, Armando Santoro, Luigina Mollica, et al.
Blood Advances
|
June 5, 2023
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study
Pierre Fenaux, Marco Gobbi, Patricia L Kropf, et al.
Hemasphere
|
August 5, 2021
Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial
Hartmut Döhner, Argiris Symeonidis, Dries Deeren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2019
Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma
Owen A O'Connor, Muhit Özcan, Eric D Jacobsen, et al.
British Journal of Haematology
|
May 21, 2021
Screening and monitoring of the BTK<sup>C481S</sup> mutation in a real-world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy
Csaba Bödör, Lili Kotmayer, Tamás László, et al.
Mycoses
|
September 5, 2022
Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope
Maria Ilaria Del Principe, Danila Seidel, Marianna Criscuolo, et al.
Leukemia
|
May 5, 2021
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
Michael Grever, Leslie Andritsos, Versha Banerji, et al.
Leukemia & Lymphoma
|
September 7, 2022
Development of a distributed international patient data registry for hairy cell leukemia
Leslie A Andritsos, Mirela Anghelina, Jasmine Neal, et al.
Blood
|
December 2, 2016
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
Michael R Grever, Omar Abdel-Wahab, Leslie A Andritsos, et al.
The Journal of Pathology. Clinical Research
|
November 21, 2023
Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation
Tamás László, Lili Kotmayer, Viktória Fésüs, et al.
Page
of 9